• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在痴呆症的临床前诊断中,基于自适应数据驱动的生物和认知标志物序列选择。

Adaptive data-driven selection of sequences of biological and cognitive markers in pre-clinical diagnosis of dementia.

机构信息

University Hospital of Old Age Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.

Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.

出版信息

Sci Rep. 2023 Apr 19;13(1):6406. doi: 10.1038/s41598-023-32867-z.

DOI:10.1038/s41598-023-32867-z
PMID:37076487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10115887/
Abstract

Effective clinical decision procedures must balance multiple competing objectives such as time-to-decision, acquisition costs, and accuracy. We describe and evaluate POSEIDON, a data-driven method for PrOspective SEquentIal DiagnOsis with Neutral zones to individualize clinical classifications. We evaluated the framework with an application in which the algorithm sequentially proposes to include cognitive, imaging, or molecular markers if a sufficiently more accurate prognosis of clinical decline to manifest Alzheimer's disease is expected. Over a wide range of cost parameter data-driven tuning lead to quantitatively lower total cost compared to ad hoc fixed sets of measurements. The classification accuracy based on all longitudinal data from participants that was acquired over 4.8 years on average was 0.89. The sequential algorithm selected 14 percent of available measurements and concluded after an average follow-up time of 0.74 years at the expense of 0.05 lower accuracy. Sequential classifiers were competitive from a multi-objective perspective since they could dominate fixed sets of measurements by making fewer errors using less resources. Nevertheless, the trade-off of competing objectives depends on inherently subjective prescribed cost parameters. Thus, despite the effectiveness of the method, the implementation into consequential clinical applications will remain controversial and evolve around the choice of cost parameters.

摘要

有效的临床决策程序必须平衡多个相互竞争的目标,如决策时间、获取成本和准确性。我们描述并评估了 POSEIDON,这是一种用于前瞻性序列诊断的基于数据的方法,具有中性区,可实现临床分类的个体化。我们通过一个应用程序评估了该框架,该程序通过算法连续提出包括认知、成像或分子标志物,如果预期对临床下降表现出阿尔茨海默病的预后有足够更准确的话。在广泛的成本参数数据驱动调优范围内,与固定的测量集相比,总费用定量降低。基于参与者在 4.8 年的平均时间内获得的所有纵向数据的分类准确性为 0.89。顺序算法选择了可用测量值的 14%,在平均随访时间为 0.74 年的情况下,以 0.05 的精度降低为代价得出结论。由于顺序分类器通过使用更少的资源犯更少的错误,因此从多目标的角度来看具有竞争力,因此可以通过固定的测量集进行竞争。然而,竞争目标的权衡取决于固有的主观规定的成本参数。因此,尽管该方法有效,但在 consequential 临床应用中的实施仍存在争议,并将围绕成本参数的选择展开。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1e/10115887/b30c395b983e/41598_2023_32867_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1e/10115887/1ef59abf4868/41598_2023_32867_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1e/10115887/297b85401be0/41598_2023_32867_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1e/10115887/650e20854877/41598_2023_32867_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1e/10115887/b486534dd98a/41598_2023_32867_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1e/10115887/c75b317084d7/41598_2023_32867_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1e/10115887/b30c395b983e/41598_2023_32867_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1e/10115887/1ef59abf4868/41598_2023_32867_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1e/10115887/297b85401be0/41598_2023_32867_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1e/10115887/650e20854877/41598_2023_32867_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1e/10115887/b486534dd98a/41598_2023_32867_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1e/10115887/c75b317084d7/41598_2023_32867_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba1e/10115887/b30c395b983e/41598_2023_32867_Fig6_HTML.jpg

相似文献

1
Adaptive data-driven selection of sequences of biological and cognitive markers in pre-clinical diagnosis of dementia.在痴呆症的临床前诊断中,基于自适应数据驱动的生物和认知标志物序列选择。
Sci Rep. 2023 Apr 19;13(1):6406. doi: 10.1038/s41598-023-32867-z.
2
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
3
Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.阿尔茨海默病风险加权多基因风险评分预测临床前阿尔茨海默病认知下降率的效用:一项前瞻性纵向研究。
J Alzheimers Dis. 2018;66(3):1193-1211. doi: 10.3233/JAD-180713.
4
The TAS Test project: a prospective longitudinal validation of new online motor-cognitive tests to detect preclinical Alzheimer's disease and estimate 5-year risks of cognitive decline and dementia.TAS Test 项目:一项新的在线运动认知测试的前瞻性纵向验证,旨在检测临床前阿尔茨海默病,并预估 5 年内认知能力下降和痴呆的风险。
BMC Neurol. 2022 Jul 18;22(1):266. doi: 10.1186/s12883-022-02772-5.
5
Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.用于轻度认知障碍患者阿尔茨海默病所致痴呆早期诊断的结构磁共振成像
Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD009628. doi: 10.1002/14651858.CD009628.pub2.
6
Development, Application, and Results from a Precision-medicine Platform that Personalizes Multi-modal Treatment Plans for Mild Alzheimer's Disease and At-risk Individuals.一个为轻度阿尔茨海默病及高危个体量身定制多模式治疗方案的精准医疗平台的开发、应用及成果。
Curr Aging Sci. 2018;11(3):173-181. doi: 10.2174/1874609811666181019101430.
7
Modelling Decline in Cognition to Decline in Function in Alzheimer's Disease.阿尔茨海默病认知下降与功能下降的建模。
Curr Alzheimer Res. 2020;17(7):635-657. doi: 10.2174/1567205017666201008105429.
8
Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer's Disease Biomarker and Mild Cognitive Impairment Diagnoses.神经心理学衰退可改善痴呆症的预测,超越阿尔茨海默病生物标志物和轻度认知障碍诊断。
J Alzheimers Dis. 2019;69(4):1171-1182. doi: 10.3233/JAD-180525.
9
The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.载脂蛋白 E4 联合年龄和阿尔茨海默病评估量表 - 认知分量表可改善对临床诊断为轻度认知障碍患者的淀粉样蛋白正电子发射断层扫描状态的预测。
Eur J Neurol. 2019 May;26(5):733-e53. doi: 10.1111/ene.13881. Epub 2019 Jan 20.
10
Internal Consistency Over Time of Subjective Cognitive Decline: Drawing Preclinical Alzheimer's Disease Trajectories.主观认知衰退的时间内一致性:绘制临床前阿尔茨海默病轨迹。
J Alzheimers Dis. 2018;66(1):173-183. doi: 10.3233/JAD-180307.

本文引用的文献

1
Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures.利用血浆磷酸化tau 蛋白联合其他可及的检测手段预测未来的阿尔茨海默病痴呆。
Nat Med. 2021 Jun;27(6):1034-1042. doi: 10.1038/s41591-021-01348-z. Epub 2021 May 24.
2
Construction, visualization and application of neutral zone classifiers.中性区分类器的构建、可视化及应用
Stat Methods Med Res. 2020 May;29(5):1420-1433. doi: 10.1177/0962280219863823. Epub 2019 Jul 18.
3
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.
常染色体显性阿尔茨海默病家系个体中神经影像学生物标志物变化的空间模式:一项纵向研究。
Lancet Neurol. 2018 Mar;17(3):241-250. doi: 10.1016/S1474-4422(18)30028-0. Epub 2018 Feb 1.
4
Estimating correlation between multivariate longitudinal data in the presence of heterogeneity.在存在异质性的情况下估计多元纵向数据之间的相关性。
BMC Med Res Methodol. 2017 Aug 17;17(1):124. doi: 10.1186/s12874-017-0398-1.
5
Maximizing the usefulness of statistical classifiers for two populations with illustrative applications.最大化具有说明性应用的两个群体的统计分类器的有用性。
Stat Methods Med Res. 2018 Aug;27(8):2344-2358. doi: 10.1177/0962280216680244. Epub 2016 Dec 5.
6
Dynamic longitudinal discriminant analysis using multiple longitudinal markers of different types.利用不同类型的多个纵向标记物进行动态纵向判别分析。
Stat Methods Med Res. 2018 Jul;27(7):2060-2080. doi: 10.1177/0962280216674496. Epub 2016 Oct 26.
7
Multivariate Longitudinal Analysis with Bivariate Correlation Test.具有双变量相关性检验的多变量纵向分析
PLoS One. 2016 Aug 18;11(8):e0159649. doi: 10.1371/journal.pone.0159649. eCollection 2016.
8
Computational neuroimaging strategies for single patient predictions.用于单病例预测的计算神经成像策略。
Neuroimage. 2017 Jan 15;145(Pt B):180-199. doi: 10.1016/j.neuroimage.2016.06.038. Epub 2016 Jun 22.
9
Studying Multivariate Change Using Multilevel Models and Latent Curve Models.使用多层模型和潜在曲线模型研究多变量变化。
Multivariate Behav Res. 1997 Jul 1;32(3):215-53. doi: 10.1207/s15327906mbr3203_1.
10
MUSE: MUlti-atlas region Segmentation utilizing Ensembles of registration algorithms and parameters, and locally optimal atlas selection.MUSE:利用配准算法和参数集合以及局部最优图谱选择的多图谱区域分割
Neuroimage. 2016 Feb 15;127:186-195. doi: 10.1016/j.neuroimage.2015.11.073. Epub 2015 Dec 8.